文献速递老年慢病共病管理多重用药

糖尿病药物与急性后康复患者急诊就诊及住院的关联

Diabetes Medications in Post-Acute Care: Association With Emergency Department Visits and Hospitalization.
PubMed 文献 · J Am Med Dir Assoc · 2025-12-10

回顾性队列研究纳入1784例≥60岁从医院转入专业护理机构进行急性后康复的患者,29.5%在30天内发生急诊就诊和/或住院。调整年龄、性别、共病指数和婚姻状态后,胰岛素使用与复合结局正相关(OR 1.275,95%CI 1.020-1.594),二甲双胍使用与复合结局负相关(OR 0.714,95%CI 0.576-0.884),其他降糖药类别未显示关联。

要点

  • 急性后康复患者中胰岛素使用与30天内急诊就诊和/或住院风险升高相关。
  • 二甲双胍使用与30天内急诊就诊和/或住院风险降低相关。
  • 其他降糖药类别(如DPP-4抑制剂、噻唑烷二酮类)未显示与复合结局的关联。

核心结论

  • 使用胰岛素的患者在SNF入院后30天内急诊就诊和/或住院率显著高于未使用胰岛素者。
  • 二甲双胍与复合结局风险降低相关,其他降糖药类别未显示关联。

主要发现

  • 30天内526例(29.5%)发生急诊就诊和/或住院。
  • 胰岛素使用与复合结局正相关(OR 1.275;95%CI 1.020-1.594)。
  • 二甲双胍使用与复合结局负相关(OR 0.714;95%CI 0.576-0.884)。
  • 其他降糖药类别(如DPP-4抑制剂、噻唑烷二酮类)与复合结局无关联。

关键数值与推荐

  • 复合结局定义为SNF急性后护理入院后30天内的急诊就诊和/或住院总次数。
  • 回归模型调整了年龄、性别、Charlson共病指数评分和婚姻状态。

临床怎么用

  • 对急性后康复的老年糖尿病患者,应关注胰岛素使用与30天内急诊就诊和/或住院风险升高的关联。
  • 二甲双胍使用与复合结局风险降低相关,但需结合患者具体情况个体化评估。

局限性

  • 原始摘要未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Diabetes is common, but optimal diabetes management for patients undergoing post-acute rehabilitation is unclear. Our primary aim was to determine whether various diabetes medication classes were associated with emergency department (ED) visits and/or hospitalization (termed the combined outcome) for this patient population. DESIGN: Retrospective cohort study. SETTINGS AND PARTICIPANTS: Eligible patients (aged ≥60 years) were discharged from hospitals to skilled nursing facilities (SNFs) for postacute care in southeast Minnesota from October 1, 2019, through June 30, 2021. METHODS: The primary outcome was the total number of ED visits and/or hospitalizations (the combined outcome) during the 30 days after SNF post-acute care admission. The predictors were insulin, metformin, sulfonylureas, dipeptidyl peptidase-4 inhibitors, thiazolidinediones, sodium-glucose cotransporter-2 inhibitors, and glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor agonists. To identify associations, we used logistic regression, with adjustment for age, gender, Charlson Comorbidity Index score, and marital status. RESULTS: The cohort comprised 1784 patients (95.3% were White, 46.1% were female). Within 30 days after their SNF admission, 526 patients (29.5%) were evaluated in the ED and/or hospitalized. Insulin use was positively associated with the combined outcome, and this association persisted after adjusting for age, gender, and comorbid conditions (odds ratio, 1.275; 95% CI, 1.020-1.594). In contrast, metformin had a reduced association with the combined outcome (odds ratio, 0.714; 95% CI, 0.576-0.884). Other diabetes medication classes (eg, dipeptidyl peptidase-4 inhibitors, thiazolidinediones) were not associated with the combined outcome. CONCLUSIONS AND IMPLICATIONS: Post-acute rehabilitation patients who used insulin had significantly higher rates of ED visits and/or hospitalizations within 30 days after SNF admission than those who did not use insulin. Further studies are needed to determine the reasons underlying this finding and to identify an optimal pharmacotherapy regimen for residents with diabetes receiving post-acute care in SNFs, who constitute a unique patient population.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Bogin MH, Takahashi PY, Johnson MG, et al. Diabetes Medications in Post-Acute Care: Association With Emergency Department Visits and Hospitalization. J Am Med Dir Assoc. 2025. PMID: 41241384. doi:10.1016/j.jamda.2025.105997

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。